POLE4 antibody
Principal name
POLE4 antibody
Alternative names for POLE4 antibody
DNA polymerase epsilon subunit 4, DNA polymerase II subunit 4, DNA polymerase epsilon subunit p12
Ncbi ID
9606, NP_063949, NP_063949.2, NP_080158.1, NM_025882, NM_019896
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of POLE4 antibody
- Kit Component:
- - KN313582G1, Pole4 gRNA vector 1 in pCas-Guide vector
- KN313582G2, Pole4 gRNA vector 2 in pCas-Guide vector
- KN313582D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human COLO205; WB Suggested Anti-POLE4 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: COLO205 cell lysate; POLE4 antibody - N-terminal region (ARP39392_P050) in Human COLO205 cells using Western Blot
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using POLE4 antibody.The picture on the right is treated with the synthesized peptide.
WB Suggested Anti-POLE4 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 312500; Positive Control: COLO205 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA315619 | POLE4 antibody |
||||||
| Rabbit polyclonal anti-POLE4 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR200545L2V | Lenti ORF particles, Pole4 (GFP-tagged) - Mouse polymerase (DNA-directed), epsilon 4 (p12 subunit) (Pole4), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR200545L1V | Lenti ORF particles, Pole4 (Myc-DDK-tagged) - Mouse polymerase (DNA-directed), epsilon 4 (p12 subunit) (Pole4), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||